Non-alcoholic fatty liver disease as metabolic consequence of obstructive sleep apnea
Obstructive sleep apnea (OSA) as a worldwide prevalent condition carries risk for cardiovascular and metabolic diseases, ultimately increasing overall mortality rates. Non-alcoholic fatty liver disease (NAFLD) can be considered as the primary metabolic disease, but also as a coexisting OSA comorbidi...
Saved in:
Main Authors: | Ninić Ana (Author), Zdravković Marija (Author), Radosavljević Vojislav (Author), Gardijan Vera (Author), Memon Lidija (Author), Vekić Jelena (Author), Spasojević-Kalimanovska Vesna (Author) |
---|---|
Format: | Book |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obstructive sleep apnea and cardiometabolic risk
by: Vekić Jelena, et al.
Published: (2019) -
Correlation of Dyslipidemia and Inflammation With Obstructive Sleep Apnea Severity
by: Viseslav Popadic, et al.
Published: (2022) -
Transforming Growth Factor-β1 and Receptor for Advanced Glycation End Products Gene Expression and Protein Levels in Adolescents with Type 1 Diabetes Mellitus
by: Ana Ninić, et al.
Published: (2021) -
Biomarkers of vitamin D status in healthy adults: Associations with serum lipid parameters: A pilot study
by: Zeljković Aleksandra, et al.
Published: (2022) -
Obstructive Sleep Apnea
by: R. Rashed, et al.
Published: (2006)